Arcus Biosciences, Inc. (RCUS)
Across 34 earnings reports since May 09, 2018, Arcus Biosciences, Inc. (RCUS) has a clear post-earnings pattern. It moves ±4.60% on average after reporting and finishes higher 44.1% of the time. Its largest post-earnings gain was +19.87% (Feb 21, 2024) and its largest decline was -10.56% (Aug 05, 2021). The next earnings report is predicted for 2026-10-13 (approximate).
Earnings reactions
How RCUS moved on each past earnings report.
Earnings Impact
Total Earnings
34
Avg Abs. Movement
±4.60%
Positive %
44.1%
Negative %
55.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 05, 2026 | ☽ POST | +1.76% | open_in_new |
| May 05, 2026 | ☽ POST | -0.46% | open_in_new |
| Feb 25, 2026 | ☽ POST | -3.6% | open_in_new |
| Oct 28, 2025 | ☽ POST | +2.06% | open_in_new |
Earnings Count
34
Total earnings in dataset
Avg Abs. Movement
±4.60%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260824 | open_in_new SEC.gov |
| 144 | 20260821 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260807 | open_in_new SEC.gov |
| 10-Q | 20260805 | open_in_new SEC.gov |
| 8-K | 20260805 | open_in_new SEC.gov |
| 4 | 20260713 | open_in_new SEC.gov |
| 144 | 20260709 | open_in_new SEC.gov |
| 144 | 20260624 | open_in_new SEC.gov |
| 4 | 20260624 | open_in_new SEC.gov |
| 144 | 20260622 | open_in_new SEC.gov |
Frequently asked about RCUS earnings
When does Arcus Biosciences, Inc. report earnings next? expand_more
Arcus Biosciences, Inc. (RCUS)'s next earnings date is approximate for 2026-10-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does RCUS stock move after earnings? expand_more
Over 34 reports, RCUS has moved an average of ±4.60% the session after earnings, closing higher 44.1% of the time.
What was RCUS's biggest post-earnings move? expand_more
RCUS's largest post-earnings gain on record was +19.87% on Feb 21, 2024, and its largest decline was -10.56% on Aug 05, 2021.
Where can I find Arcus Biosciences, Inc.'s SEC filings? expand_more
All of Arcus Biosciences, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right